Revenue at North Chicago-based AbbVie dove by nearly 10% during the first few months of this year - a drop that comes as its best-selling drug Humira faces competition for the first time in the U.S.
The company reported net revenues of $12.23 billion for the first quarter of this year, a decrease of 9.7% on a reported basis compared with the first three months of last year, but slightly beating analysts' average estimate of $12.17 billion.
The company reported net revenues of $12.23 billion for the first quarter of this year, a decrease of 9.7% on a reported basis compared with the first three months of last year, but slightly beating analysts' average estimate of $12.17 billion.
[
add
]
[
|
|
...
]